Greenlight HPS-120W vs Greenlight XPS-180W Laser Vaporization of the Prostate for Benign Prostatic Hyperplasia: A Global, Multi-center, and Prospective Comparative Analysis According to Prostate Size
CUA Online Library. Ben-Zvi T. 06/24/13; 31529; MP-04.16
Disclosure(s): Consultant work - AMS, Minnetonka, Minnesota, USA
Henry Woo(2), Mahmood A. Hai(3), Alexis E. Te(4), Bilal Chughtai(4),
Richard Lee(4) , Matthew Rutman(5) , Ricardo R. Gonzalez (6), Neil Barber(7), and Kevin C. Zorn(1)
1- CHUM Section of Urology Department of Surgery, Centre Hospitalier de l’Université de Montréal, QC, Canada 2- Department of Urology, Westmead Hospital, The University of Sydney, Sydney, Australia 3- Department of Urology, Oakwood Annapolis Hospital, Wayne, MI, USA 4- Department of Urology, Cornell Weill Medical College, New York Presbyterian Hospital, NY, USA 5- Department of Urology, Columbia University, New York Presbyterian Hospital NY, USA 6- Department of Urology, The Methodist Hospital, Houston, TX, USA 7- Department of Urology Frimley Park Hospital, Frimley, England.
CLICK HERE TO LOGIN
REGULAR CONTENT
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Rate & Comment (0)
To evaluate the surgical performance and impact of prostate volume (PV) of the new-generation Greenlight XPS-180W laser system (AMS, Minnetonka, MI, USA) in comparison with the former generation HPS-120W system for the treatment of BPH by photo-selective vaporization of the prostate (PVP) in a multi-user, multi-national experience.
To evaluate the surgical performance and impact of prostate volume (PV) of the new-generation Greenlight XPS-180W laser system (AMS, Minnetonka, MI, USA) in comparison with the former generation HPS-120W system for the treatment of BPH by photo-selective vaporization of the prostate (PVP) in a multi-user, multi-national experience.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}